Completing the Philips Respironics medical device recall remains our highest priority. With the remediation of the sleep therapy devices almost complete and remediation of the ventilators ongoing, it is important that patients, Durable Medical Equipment providers (DMEs) and clinicians are informed on the latest updates. We will continue to prioritize remediation of registered sleep and respiratory care devices and will also continue to accept returned affected devices at no cost.
If you have questions on the closure of affected device registration or the US Patient Portal closure, please contact [email protected] and provide your name, phone number, shipping address (we cannot accept P.O. boxes), affected device serial number and your specific question. Failure to provide this information could lead to a delay in response.
We are committed to remediating affected ventilators in alignment with the relevant competent authorities, and continue to work with independent testing laboratories to conduct extensive testing and analysis of the affected devices.
Philips Respironics will communicate with DMEs directly throughout the remediation process. If you are a patient or caregiver with an affected Philips Respironics ventilation device, you do not need to take any action. All ventilation remediation will be done via your DME.
As of April 2, 2026:
US actionable* registrations: 133,000
Devices** remediated in the US: 83,000
* Actionable registrations are those that contain the necessary information needed to complete the remediation and devices are in possession of customer.
** Figure reflects remediation through financial compensation program, or a device rework remediation option.
Click here for ventilation news and updates.
Globally, we have remediated 99% of actionable* sleep therapy device registrations to date.
Continuing to remediate new and existing registrations remains our priority. We will make multiple attempts to ensure we have the information needed to place an order, and will provide responding patients with remediation options.
As of April 2, 2026:
US actionable* registrations: 2.691 million
Patients** remediated in the US: 2.684 million
*Actionable registrations are those that contain the necessary information needed to complete the remediation and are not awaiting further information.
** Remediated patients include those who have received a new, recertified or an alternative device sent as replacements for affected units, those who have had devices shipped to their DME directly handling patient remediations, or those who received financial payment.